AUG 15, 2018 12:27 AM PDT

Peripheral Nerve Blockers Treat Facial Pain

WRITTEN BY: Nouran Amin

A new research study published in the American Journal of Emergency Medicine explains the use of peripheral nerve inhibitors in the treatment of facial pain condition known as Trigeminal Neuralgia (TGN). TGN involves sudden episodes of severe facial pain that can significantly reduce the quality of life for affected individuals.

Some patients seek highly precise invasive procedures when proper medication fails to manage the pain. However, invasive procedures often leave patients with discomfort and the long period of numbness. Fortunately, the study examined alternatives that can give patients promising results with less discomfort. Such an alternative is Peripheral Trigeminal Nerve Blocks (PTNB). PTNB can be thought of as another procedure in which a numbing medication is administered through an injection at the site where the problem nerve reaches the facial pain area. Although PTNB serves as a promising alternative, the efficacy of this particular drug has not been well studied in both short-term and long-term management of TGN.

Image Retrieved From Unsplash, www.unsplash.com

During a case series in the American Journal of Emergency Medicine, Michael Perloff, MD, a clinical neurologist and an assistant professor of neurology at Boston University School of Medicine, examined nine TGN patients that were treated with PTNB. Perloff found that all nine patients had an immediate relief of their pain after the administered procedure, with many reporting pain-free feeling. Additionally, six of these nine patients reported continued pain relief from a range of one to eight months that followed the procedure, with two of the patients experiencing a complete resolution of their pain months after the administered injections. Perloff believes these results to be an encouraging step towards effective pain management for patients with TGN. "PTNB can be a simple, safe alternative compared to opioids, invasive ganglion level procedures or surgery."

Source: Boston University School of Medicine

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 01, 2018
Drug Discovery
AUG 01, 2018
Effective Drug For Disorders of Copper Metabolism
According to a paper in the Proceedings of the National Academy of Sciences, a research team led by Dr. Vishal Gohil of Texas A&M AgriLife Research in...
AUG 08, 2018
Drug Discovery
AUG 08, 2018
Old Drug Offers Novel Treatment For Hair Loss
According to researchers from The University of Manchester's Centre for Dermatology Research, a recent developed drug may serve as the key to treating ...
AUG 27, 2018
Cardiology
AUG 27, 2018
Drug Reduces Deaths and Hospitalization from Heart Failure
New drug reduces deaths and hospitalization rates, while also improving quality of life, for patients with rare type of cardiomyopathy....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
NOV 07, 2018
Drug Discovery
NOV 07, 2018
Modifying Antibiotics For Drug Resistant Infections
In a study published in Nature Chemistry, researches at MIT were able to create a new chemical reaction that has the ability to modify antibiotics to make ...
NOV 07, 2018
Drug Discovery
NOV 07, 2018
Zebrafish Bacterial Gut Protein Delays Death by Septic Shock
At the University of Oregon, researchers identified a novel anti-inflammatory protein that is secreted by the common gut bacterium in zebrafish. The protei...
Loading Comments...